Digestives & Intestinal Remedies - Northern Europe

  • Northern Europe
  • In 2024, the Digestives & Intestinal Remedies market market in Northern Europe generated a revenue of US$200.10m.
  • It is projected to experience an annual growth rate of 2.57% (CAGR 2024-2029).
  • When compared globally, in China leads the market with a revenue of US$4,408.00m in 2024.
  • In terms of per capita income, each person in Northern Europe generated US$5.91 in revenue in 2024.
  • In Northern Europe, there is a growing trend towards natural and herbal digestive remedies, as consumers seek more holistic and sustainable solutions for their gastrointestinal health.

Key regions: Canada, United States, Australia, Brazil, Japan

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestives & Intestinal Remedies market in Northern Europe is experiencing steady growth due to changing customer preferences and increasing awareness about digestive health.

Customer preferences:
Customers in Northern Europe have become more health-conscious and are seeking natural and organic remedies for digestive issues. They are increasingly looking for products that are free from artificial ingredients and have a minimal impact on the environment. This shift in preferences has led to a rise in demand for herbal and plant-based digestive remedies, as well as probiotics and prebiotics that promote gut health.

Trends in the market:
One of the key trends in the Digestives & Intestinal Remedies market in Northern Europe is the growing popularity of fermented foods and drinks. Fermented products such as sauerkraut, kefir, and kombucha are rich in probiotics, which help maintain a healthy balance of gut bacteria. This trend is driven by the increasing awareness about the importance of gut health and the role it plays in overall well-being. Another trend in the market is the rising demand for digestive supplements and enzymes. These products help improve digestion and alleviate symptoms such as bloating, gas, and indigestion. The increasing prevalence of digestive disorders, such as irritable bowel syndrome (IBS) and lactose intolerance, is driving the demand for these products.

Local special circumstances:
In Northern Europe, there is a strong emphasis on sustainability and environmental responsibility. Customers are willing to pay a premium for products that are produced using sustainable practices and have a minimal carbon footprint. This has led to the emergence of local and artisanal brands that focus on using locally sourced ingredients and eco-friendly packaging. Furthermore, the region has a well-developed healthcare system and high levels of health literacy. This enables customers to make informed choices about their health and seek out products that are backed by scientific research and evidence.

Underlying macroeconomic factors:
The Digestives & Intestinal Remedies market in Northern Europe is also influenced by macroeconomic factors such as the increasing disposable income and aging population. As people have more disposable income, they are willing to spend on products that improve their health and well-being. The aging population is more prone to digestive issues and is therefore a key target market for digestive remedies. In conclusion, the Digestives & Intestinal Remedies market in Northern Europe is witnessing growth due to changing customer preferences, increasing awareness about digestive health, and the emphasis on sustainability. The popularity of fermented foods, the demand for digestive supplements, and the focus on local and artisanal brands are some of the key trends in the market. The region's well-developed healthcare system and high levels of health literacy also contribute to the growth of the market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)